Latest news in cooperation with Nordic Life Science

IgG antibodies play an unexpected role in atherosclerosis

25 March 2019 | 9:00 am
Stephen Malin and Monica Centa
A Karolinska Institutet study on mice shows that the antibodies stabilise the plaque that accumulates on the artery walls, which reduces the risk of it rupturing and causing a blood clot. Atherosclerosis is characterised by the narrowing of the arterial walls resulting from the accumulation of lipids and cells – the so-called atherosclerotic plaque. When […]
Latest news in cooperation with Nordic Life Science

Elekta receives Medical Device License from Health Canada

25 March 2019 | 8:37 am
Elekta Unity MR Linac
The company’s Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received a Medical Device License from Health Canada, clearing the technology for commercial sales in Canada. “We are pleased to have achieved this important milestone toward making Elekta Unity available in Canada and expect that this important new treatment option will become available to […]
Latest news in cooperation with Nordic Life Science

Zhejiang NHU invests €5.5 million in Danish biotech start-up

22 March 2019 | 1:00 pm
CysBio team
The Chinese fine chemical company Zhejiang NHU will invest €5.5 M in the biotech start-up CysBio to develop new and affordable biochemicals. CysBio is making cost-effective and novel biochemicals via sustainable fermentation processes. Through advanced synthetic biology and metabolic engineering approaches microorganisms are engineered to convert simple sugars into desired biochemical products. This makes it […]
Latest news in cooperation with Nordic Life Science

LIDDS to evaluate a possible listing

22 March 2019 | 10:01 am
LIDDS to evaluate a possible listing
The company will evaluate a possible listing of its shares on Nasdaq Stockholm’s Main Market during 2020 and will engage advisors to explore this potential relisting. LIDDS is in a strong growth and expansion phase with several key projects in clinical and pre-clinical phases, including the Phase IIb Liproca Depot study, the Phase I NanoZolid-docetaxel […]
Latest news in cooperation with Nordic Life Science

Cantargia makes directed share issue of approximately SEK 106 million

22 March 2019 | 7:23 am
Cantargia CEO
The proceeds from the share issue enable expanded investments in the company’s main project, CAN04 (nidanilimab), with a new clinical study in the US and an expansion of the most promising patient sub group of the ongoing clinical CANFOUR study. The investors are a number of Nordic institutional investors; Alecta (approximately SEK 76.5 million), Handelsbanken […]
Latest news in cooperation with Nordic Life Science

Affibody announces co-development agreement with Alexion

20 March 2019 | 11:00 am
David Bejker
Swedish Affibody and US Alexion Pharmaceuticals have announced a partnership to co-develop ABY-039 for rare Immunoglobulin G (IgG)-mediated autoimmune diseases. Under the terms of the agreement, Alexion will provide Affibody with an upfront payment of $25 million, with the potential for additional development- and sales-based milestones of up to $625 million and tiered low double-digit […]
Latest news in cooperation with Nordic Life Science

Lobsor granted US patent

20 March 2019 | 9:32 am
Roger Bolsoy
Lobsor Pharmaceuticals has been granted the US patent covering a pharmaceutical composition for the treatment of neurodegenerative disorders such as Parkinson’s disease. Lobsor has earlier received market authorization by the Swedish Medical Products Agency (MPA) for their lead product, Lecigon, a new therapeutic system for symptomatic treatment of Advanced Parkinson’s disease (APD). Lecigon comprises the […]
Latest news in cooperation with Nordic Life Science

Pilloxa in strategic partnership with Bayer

20 March 2019 | 8:40 am
Pilloxa digital dosett
Swedish Pilloxa is initiating a collaboration with the Scandinavian branch of Bayer and get the opportunity to introduce more people to their smart pillbox through Bayer’s network, both in Scandinavia and globally. “We see great potential in this innovation. For someone not too familiar in the subject it might seem like a trivial task to take […]
Latest news in cooperation with Nordic Life Science

Protective antibodies also found in premature babies

19 March 2019 | 4:21 am
Dieudonné-Nkulikiyimfura-Petter-Brodin-Christian-Pou
Even premature babies carry anti-viral antibodies transferred from the mother, researchers at Karolinska Institutet in Sweden report in a paper on maternal antibodies in newborns, published in the journal Nature Medicine. Antibodies are transferred from the mother’s blood to the fetus that give the newborn passive defense against infection. Since most of this process takes place […]
Latest news in cooperation with Nordic Life Science

Preclinical data from Alligator demonstrate strong anti-tumor effects

19 March 2019 | 4:14 am
Christina Furebring
The company will present these preclinical data for the drug candidate ATOR-1017 at the 4th Annual Immuno-oncology Summit Europe, to be held in London on March 18-22, 2019. ATOR-1017 is a monoclonal antibody in development for the treatment of metastasizing cancer. It activates the co-stimulatory receptor 4-1BB and its immuno-stimulatory function is dependent on cross-linking to Fc-gamma […]
Login